nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—P2RY2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0477	0.118	CbGpPWpGaD
Suramin—FSHR—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0461	0.114	CbGpPWpGaD
Suramin—SIRT1—midbrain—Gilles de la Tourette syndrome	0.0317	0.0533	CbGeAlD
Suramin—SIRT5—nervous system—Gilles de la Tourette syndrome	0.0315	0.0529	CbGeAlD
Suramin—SIRT5—central nervous system—Gilles de la Tourette syndrome	0.0303	0.0509	CbGeAlD
Suramin—P2RX4—nervous system—Gilles de la Tourette syndrome	0.0297	0.05	CbGeAlD
Suramin—RYR1—midbrain—Gilles de la Tourette syndrome	0.0293	0.0493	CbGeAlD
Suramin—P2RX4—central nervous system—Gilles de la Tourette syndrome	0.0286	0.0482	CbGeAlD
Suramin—SIRT1—nervous system—Gilles de la Tourette syndrome	0.0261	0.0438	CbGeAlD
Suramin—ARSA—nervous system—Gilles de la Tourette syndrome	0.0257	0.0433	CbGeAlD
Suramin—SIRT1—central nervous system—Gilles de la Tourette syndrome	0.0251	0.0422	CbGeAlD
Suramin—ARSA—central nervous system—Gilles de la Tourette syndrome	0.0248	0.0417	CbGeAlD
Suramin—RYR1—nervous system—Gilles de la Tourette syndrome	0.0241	0.0405	CbGeAlD
Suramin—SIRT5—brain—Gilles de la Tourette syndrome	0.024	0.0404	CbGeAlD
Suramin—RYR1—central nervous system—Gilles de la Tourette syndrome	0.0232	0.039	CbGeAlD
Suramin—P2RX4—brain—Gilles de la Tourette syndrome	0.0227	0.0382	CbGeAlD
Suramin—PLA2G2A—midbrain—Gilles de la Tourette syndrome	0.0222	0.0373	CbGeAlD
Suramin—SIRT1—brain—Gilles de la Tourette syndrome	0.0199	0.0335	CbGeAlD
Suramin—ARSA—brain—Gilles de la Tourette syndrome	0.0197	0.0331	CbGeAlD
Suramin—RYR1—brain—Gilles de la Tourette syndrome	0.0184	0.031	CbGeAlD
Suramin—PLA2G2A—nervous system—Gilles de la Tourette syndrome	0.0183	0.0307	CbGeAlD
Suramin—PLA2G2A—central nervous system—Gilles de la Tourette syndrome	0.0176	0.0296	CbGeAlD
Suramin—FSHR—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.0175	0.0431	CbGpPWpGaD
Suramin—FSHR—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.017	0.0418	CbGpPWpGaD
Suramin—PLA2G4A—midbrain—Gilles de la Tourette syndrome	0.0154	0.026	CbGeAlD
Suramin—PLA2G2A—brain—Gilles de la Tourette syndrome	0.014	0.0235	CbGeAlD
Suramin—F2—nervous system—Gilles de la Tourette syndrome	0.0138	0.0232	CbGeAlD
Suramin—F2—central nervous system—Gilles de la Tourette syndrome	0.0133	0.0223	CbGeAlD
Suramin—PLA2G4A—nervous system—Gilles de la Tourette syndrome	0.0127	0.0213	CbGeAlD
Suramin—PLA2G4A—central nervous system—Gilles de la Tourette syndrome	0.0122	0.0206	CbGeAlD
Suramin—FSHR—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.0111	0.0273	CbGpPWpGaD
Suramin—F2—brain—Gilles de la Tourette syndrome	0.0105	0.0177	CbGeAlD
Suramin—SIRT1—Regulation of retinoblastoma protein—MET—Gilles de la Tourette syndrome	0.0102	0.0251	CbGpPWpGaD
Suramin—PLA2G4A—brain—Gilles de la Tourette syndrome	0.0097	0.0163	CbGeAlD
Suramin—P2RY2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00786	0.0194	CbGpPWpGaD
Suramin—P2RY2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00763	0.0188	CbGpPWpGaD
Suramin—FSHR—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00759	0.0187	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00741	0.0183	CbGpPWpGaD
Suramin—FSHR—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00737	0.0182	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00719	0.0177	CbGpPWpGaD
Suramin—P2RY2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0071	0.0175	CbGpPWpGaD
Suramin—FSHR—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00686	0.0169	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00673	0.0166	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.0067	0.0165	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00653	0.0161	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0065	0.016	CbGpPWpGaD
Suramin—P2RY2—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00644	0.0159	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00631	0.0156	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00609	0.015	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00588	0.0145	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00576	0.0142	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00513	0.0126	CbGpPWpGaD
Suramin—P2RY2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00498	0.0123	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00498	0.0123	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00495	0.0122	CbGpPWpGaD
Suramin—FSHR—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00481	0.0118	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00481	0.0118	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00464	0.0114	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00448	0.011	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00426	0.0105	CbGpPWpGaD
Suramin—ARSA—Metabolism—HDC—Gilles de la Tourette syndrome	0.00423	0.0104	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00412	0.0102	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00325	0.008	CbGpPWpGaD
Suramin—RYR1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00323	0.00795	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00314	0.00773	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.0029	0.00714	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00281	0.00693	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.0028	0.0069	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—HDC—Gilles de la Tourette syndrome	0.00273	0.00672	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00272	0.0067	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00263	0.00649	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00262	0.00646	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00255	0.0063	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00254	0.00626	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00253	0.00624	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00247	0.00608	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00238	0.00587	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.0023	0.00566	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00192	0.00474	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00187	0.0046	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00184	0.00454	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00183	0.00452	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00177	0.00437	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00174	0.00429	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00167	0.00411	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00165	0.00406	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00161	0.00397	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00155	0.00383	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00151	0.00372	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.0015	0.0037	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00146	0.00361	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00146	0.00359	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00142	0.00351	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00141	0.00346	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00136	0.00335	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00132	0.00327	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—HDC—Gilles de la Tourette syndrome	0.00128	0.00317	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00122	0.003	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000984	0.00243	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00095	0.00234	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000928	0.00229	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000828	0.00204	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000803	0.00198	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000752	0.00185	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000749	0.00185	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00073	0.0018	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000687	0.0017	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00068	0.00168	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000667	0.00165	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000622	0.00153	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000524	0.00129	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000476	0.00117	CbGpPWpGaD
Suramin—F2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000444	0.00109	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000435	0.00107	CbGpPWpGaD
Suramin—F2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000431	0.00106	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000406	0.001	CbGpPWpGaD
Suramin—F2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000402	0.00099	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000394	0.000972	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000367	0.000906	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000281	0.000693	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000257	0.000634	CbGpPWpGaD
